| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,027 |
Update - Notification of buy-back - AOV
|
26 Feb 2025 9:01AM |
$9.940 |
$7.560 |
fallen by
23.94%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$41 |
Cleansing Notice
|
26 Feb 2025 9:01AM |
$0.099 |
$0.062 |
fallen by
37.37%
|
|
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$402 |
Update - Dividend/Distribution - CDP
|
26 Feb 2025 9:00AM |
$4.630 |
$4.860 |
risen by
4.97%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$7,154 |
Presentation - Half year results 2025
|
26 Feb 2025 9:00AM |
$14.020 |
$13.520 |
fallen by
3.57%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aggregated revenue of $5,989 million in H1 FY25, a 6.8% increase versus H1 FY24.
- Underlying EBITA growth of 9.0% to $376 million.
- Sustainability-related revenue made up 58% of total revenue.
- Interim dividend declared at 25 cents, unchanged from H1 FY24.
- Strong cash conversion ratio reported at 97.5%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$7,154 |
ASX release - Half year results 2025
|
26 Feb 2025 9:00AM |
$14.020 |
$13.520 |
fallen by
3.57%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory net profit increased by 55.4% to $216 million.
- Underlying EBITA grew by 9.0% to $376 million.
- Aggregate revenue reached $5,989 million, up 6.8% year-on-year.
- Interim dividend declared at 25 cents per share.
- Bookings increased to $6.6 billion.
- Backlog decreased to $12.7 billion.
- FY25 outlook targeting low double-digit EBITA growth.
- Continued focus on sustainable projects accounting for 62% of expected revenue.
- Strong capital management with a cash conversion ratio of 97.5%.
- Intention to undertake an on-market share buy-back of up to $500 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$402 |
Appendix 4D & Half Year Report
|
26 Feb 2025 8:59AM |
$4.630 |
$4.860 |
risen by
4.97%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$7,154 |
Dividend/Distribution - WOR
|
26 Feb 2025 8:59AM |
$14.020 |
$13.520 |
fallen by
3.57%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$105 |
Imugene OnCARlytics Patent Allowance in China
|
26 Feb 2025 8:58AM |
$0.036 |
$0.014 |
fallen by
61.11%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Patent protects Imugene's CD19-expressing oncolytic virus in China.
- Patent covers method of composition and use until 2038.
- OnCARlytics targets solid tumor cells to express CD19 protein.
- Imugene is conducting a dose escalation trial in the U.S. with approximately 40 patients.
- Intellectual property protection is a priority for Imugene's strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$336 |
Application for quotation of securities - AMH
|
26 Feb 2025 8:58AM |
$1.150 |
$1.065 |
fallen by
7.39%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$845 |
Dividend/Distribution - IDX
|
26 Feb 2025 8:58AM |
$2.860 |
$2.270 |
fallen by
20.63%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$7,154 |
Appendix 4D and Interim Financial Report HY2025
|
26 Feb 2025 8:58AM |
$14.020 |
$13.520 |
fallen by
3.57%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory profit after tax increased to $183 million compared to $106 million last year.
- Revenue decreased to $5,610 million from $5,821 million.
- Underlying profit after tax increased by $28 million to $183 million.
- The EBITA margin improved to 6.3% from 5.1%.
- Worley announced an on-market share buy-back of up to $500 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$66 |
Syerston Scandium Project Presentation
|
26 Feb 2025 8:58AM |
$0.295 |
$0.730 |
risen by
147.46%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$7,154 |
Worley announces share buy-back program
|
26 Feb 2025 8:57AM |
$14.020 |
$13.520 |
fallen by
3.57%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Worley Limited announces a share buy-back program of up to $500 million.
- The buy-back reflects the Board's confidence in the company's financial position.
- It is part of a broader capital management strategy to enhance shareholder value.
- Worley aims to continue investing in strategic initiatives for growth.
- The buy-back will commence in March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$63 |
Half Year Results Investor Presentation
|
26 Feb 2025 8:56AM |
$0.935 |
$0.695 |
fallen by
25.67%
|
|
EGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Enero Group reported increased revenue and cash earnings for FY25.
- Gold sales during 1H25 were significant with a strong average price per ounce.
- The company outlined production guidance for FY25, expecting between 1,650 Koz and 1,800 Koz of gold sold.
- The presentation highlighted operational efficiencies contributing to performance.
- Enero Group emphasized its commitment to environmental and social governance initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$409 |
2025 Half Year Investor Presentation
|
26 Feb 2025 8:56AM |
$7.220 |
$5.030 |
fallen by
30.33%
|
|
MYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Mayne Pharma's revenue increased 32% to US$62.3 million in Women's Health.
- Strong sales growth driven by NEXTSTELLIS®, BIJUVA®, and IMVEXXY®.
- Total revenue for 1H FY25 was US$213.1 million, up 13% from the previous year.
- Gross margin improved to 61.4% compared to 56.3% in 1H FY24.
- Underlying EBITDA increased by 288% year-on-year.
- A Scheme Implementation Deed was signed for acquisition by Cosette Pharmaceuticals.
- The acquisition values Mayne Pharma at approximately A$672 million.
- The acquisition price represents a 37% premium over the share price prior to the announcement.
- Mayne Pharma's Board recommends shareholders vote in favor of the acquisition.
- The Women's Health market is projected to grow significantly, driven by increased awareness and government support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Apiam Animal Health Limited (AHX) ORDINARY FULLY PAID |
Health Care |
$83 |
Impairment of underperforming NSW Equine Business
|
26 Feb 2025 8:55AM |
$0.415 |
$0.450 |
risen by
8.43%
|
|
AHX - Price-sensitive ASX Announcement
Full Release
Key Points
- Apiam Animal Health Limited announced divestment of underperforming equine business.
- Impairment loss of $4.5 million recorded in H1 FY25 financial accounts.
- Divestment aligns with ongoing portfolio management efforts.
- Exit of small clinic in Hastings, VIC, and US Joint Venture planned.
- Group revenue expected to decrease by approximately $2.3 million.
- EBIT anticipated to increase by around $1 million.
- Core veterinary services continue to show resilient growth and strong profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$409 |
2025 Half Year Media Release
|
26 Feb 2025 8:54AM |
$7.220 |
$5.030 |
fallen by
30.33%
|
|
MYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported revenue increased by 13% to A$213.1 million.
- Underlying EBITDA rose 288% to A$31.0 million.
- Direct contribution from business segments improved 60% to A$65.0 million.
- Women’s Health segment saw revenue growth of 30% to A$94.3 million.
- Cosette Pharmaceuticals agreed to acquire 100% of Mayne Pharma shares at A$7.40 per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| H&G High Conviction Limited (HCF) ORDINARY FULLY PAID |
Financials |
$0 |
Appendix 4D and Half Year Report
|
26 Feb 2025 8:54AM |
$0.805 |
$0.025 |
fallen by
96.89%
|
|
HCF - Price-sensitive ASX Announcement
Full Release
Key Points
- HCF posted a -3.8% post-tax return for the first half of FY2025.
- Underperformed compared to the ASX Small Ordinaries Accumulation Index which gained 5.5%.
- Since IPO, average post-tax returns have been 4.8% per annum.
- Initiated a 10% share buyback, repurchasing 678,194 shares.
- Top contributors included SciDev Ltd due to growth in PFAS treatment.
- VEEM and DUG Technology faced near-term headwinds.
- Post-tax NTA per share declined to $0.98.
- No dividend declared for the half year ended 31 December 2024.
- The company remains focused on long-term investment strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$308 |
BlueBet Offer to Acquire PointsBet
|
26 Feb 2025 8:54AM |
$0.340 |
$0.300 |
fallen by
11.76%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- BlueBet offers to acquire PointsBet for $340-$360 million.
- The offer includes a cash pool of $240-$260 million and scrip consideration of $100-$120 million.
- Expected annual synergies from the acquisition are at least $40 million.
- The transaction aims to provide strategic and financial benefits for PointsBet shareholders.
- BlueBet has secured funding arrangements to support the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$395 |
BBT: BlueBet Offer to Acquire PointsBet
|
26 Feb 2025 8:54AM |
$0.830 |
$1.190 |
risen by
43.37%
|
|
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$409 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:54AM |
$7.220 |
$5.030 |
fallen by
30.33%
|
|
MYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 13% to $213.1 million.
- Net loss improved to $25.5 million from $70.5 million.
- Strong performance in Women's Health and Dermatology segments.
- Class action lawsuit settled for $38 million.
- Company facing ongoing legal investigations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emerald Resources NL (EMR) ORDINARY FULLY PAID |
Materials |
$3,050 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:53AM |
$4.030 |
$4.640 |
risen by
15.14%
|
|
EMR - Price-sensitive ASX Announcement
Full Release
Key Points
- 36% increase in revenue due to higher gold production and prices.
- Profit after tax attributable to owners rose by 45% to $59.7 million.
- Consolidated cash position improved to $217.5 million.
- Debt repayments totaled US$58.5 million, with a remaining balance of US$6.5 million.
- Successful divestment of the Southern Cross Gold Project.
- Resource estimates for the Okvau Gold Mine and Dingo Range Gold Project show positive potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Scentre Group (SCG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$18,751 |
Full Year Announcement and Results Presentation
|
26 Feb 2025 8:52AM |
$3.640 |
$3.600 |
fallen by
1.10%
|
|
| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$21,359 |
IAG announces wholesale subordinated note issue
|
26 Feb 2025 8:52AM |
$7.850 |
$9.030 |
risen by
15.03%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$56 |
Update - Notification of buy-back - BOL
|
26 Feb 2025 8:52AM |
$1.530 |
$1.350 |
fallen by
11.76%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
